🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
1,179

Quick answer

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. TAK-954 Placebo

    Takeda

    Postoperative Gastrointestinal Dysfunction

    phase 2 small molecule completed

    1 trial

  2. TAK-981

    Takeda

    Lymphoma, Non-Hodgkin

    phase 2 small molecule terminated

    1 trial

  3. TAK-981

    Takeda

    Neoplasms

    phase 2 small molecule terminated

    1 trial

  4. TAK-981

    Takeda

    Advanced or Metastatic Solid Tumors

    phase 2 small molecule completed

    1 trial

  5. TAK-981

    Takeda

    Relapsed and/or Refractory Multiple Myeloma (RRMM)

    phase 2 small molecule terminated

    1 trial

  6. TAK-994

    Takeda

    Narcolepsy Type 1 (NT1)

    phase 2 small molecule terminated

    1 trial

  7. TAK-994

    Takeda

    Narcolepsy Type 1 (NT 1)

    phase 2 small molecule terminated

    1 trial

  8. TAK228

    Takeda

    Lymphoma

    phase 2 small molecule terminated

    1 trial

  9. TD-8954

    Takeda

    Enteral Feeding Intolerance

    phase 2 small molecule completed

    1 trial

  10. TDV

    Takeda

    Healthy

    phase 2 mab completed

    1 trial

  11. TDV Liquid Formulation 1

    Takeda

    Dengue Fever

    phase 2 small molecule completed

    1 trial

  12. TIMP-GLIA

    Takeda

    Celiac Disease

    phase 2 small molecule completed

    2 trials

  13. Tak-228 & Tak-117

    Takeda

    Triple Negative Breast Cancer

    phase 2 small molecule completed

    1 trial

  14. Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

    Takeda

    Dengue Fever

    phase 2 mab completed

    2 trials

  15. Teduglutide

    Takeda

    Postoperative Fistula

    phase 2 small molecule completed

    1 trial

  16. Teduglutide (ALX-0600)

    Takeda

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  17. Tislelizumab

    Takeda

    Minimal Residual Disease

    phase 2 small molecule active

    1 trial

  18. Udenafil

    Takeda

    Erectile Dysfunction

    phase 2 small molecule terminated

    2 trials

  19. VP20621

    Takeda

    Clostridium Difficile Infection

    phase 2 mab completed

    1 trial

  20. Vedolizumab

    Takeda

    Allogeneic Hematopoietic Stem Cell Transplantation

    phase 2 small molecule completed

    2 trials

  21. Vedolizumab

    Takeda

    Collagenous Gastritis

    phase 2 mab active

    1 trial

  22. Vedolizumab

    Takeda

    Celiac Disease

    phase 2 small molecule terminated

    1 trial

  23. Vedolizumab 300 MG Injection [Entyvio]

    Takeda

    Immune Checkpoint Inhibitor-Related Colitis

    phase 2 small molecule active

    1 trial

  24. Vedolizumab intravenous injection

    Takeda

    Ulcerative Colitis

    phase 2 small molecule terminated

    1 trial

  25. Veltuzumab

    Takeda

    Rheumatoid Arthritis

    phase 2 small molecule terminated

    1 trial

  26. Vidaza 25 mg/ml powder for suspension for injection, Azacitidin STADA 25 mg/ml Pulver zur Herstellung einer Injektionssuspension, Venclyxto 10 mg film-coated tablets, Venclyxto 50 mg film-coated tablets, Azacitidine Mylan 25 mg/mL powder for suspension for injection, Azacitidine Mylan 25 mg/mL powder for suspension for injection, pevonedistat hydrochloride, Venclyxto 100 mg film-coated tablets

    Takeda

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  27. Vonoprazan

    Takeda

    Gastroesophageal Reflux

    phase 2 small molecule completed

    1 trial

  28. Vortioxetine

    Takeda

    Binge Eating Disorder

    phase 2 small molecule completed

    1 trial

  29. Vortioxetine (IV)

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  30. ZASOCITINIB

    Takeda

    Moderate to Severely Active Ulcerative Colitis & Moderate to Severely Active Crohn's Disease

    phase 2 small molecule active

    1 trial

  31. ZASOCITINIB, Matching Placebo for TAK-279

    Takeda

    Hidradenitis Suppurativa

    phase 2 small molecule active

    1 trial

  32. ZASOCITINIB, ZASOCITINIB, White opaque, hard hypromellose capsule, size 3 containing same excipients as TAK-279 active capsule

    Takeda

    Non-segmental vitiligo

    phase 2 small molecule active

    1 trial

  33. ZED1227 + SIGE

    Takeda

    Celiac Disease

    phase 2 small molecule active

    1 trial

  34. Zasocitinib

    Takeda

    Crohn's Disease

    phase 2 small molecule active

    2 trials

  35. Zasocitinib

    Takeda

    Nonsegmental Vitiligo

    phase 2 small molecule active

    1 trial

  36. Zasocitinib (Dose A)

    Takeda

    Hidradenitis Suppurativa

    phase 2 small molecule active

    1 trial

  37. alisertib

    Takeda

    Malignant Rhabdoid Tumor

    phase 2 small molecule active

    1 trial

  38. anagrelide hydrochloride

    Takeda

    Essential Thrombocythaemia

    phase 2 small molecule completed

    1 trial

  39. budesonide

    Takeda

    Eosinophilic Esophagitis (EoE)

    phase 2 small molecule completed

    1 trial

  40. ecallantide 60 mg

    Takeda

    ACE Inhibitor Induced Angioedema

    phase 2 small molecule terminated

    1 trial

  41. elritercept

    Takeda

    Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS).

    phase 2 small molecule active

    1 trial

  42. fruquintinib

    Takeda

    Colon Cancer

    phase 2 small molecule active

    1 trial

  43. lanadelumab

    Takeda

    COVID-19

    phase 2 mab completed

    1 trial

  44. lisdexamfetamine dimesylate (SPD489)

    Takeda

    Binge Eating Disorder

    phase 2 small molecule completed

    1 trial

  45. metformin

    Takeda

    Type 2 Diabetes

    phase 2 small molecule completed

    1 trial

  46. oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab

    Takeda

    Colorectal Carcinoma

    phase 2 small molecule completed

    1 trial

  47. peginesatide

    Takeda

    Anemia

    phase 2 small molecule completed

    5 trials

  48. pioglitazone

    Takeda

    Asthma

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.